These data and analyses support the research article "Re-evaluating the LD50 requirements in the codified potency testing of veterinary vaccines containing Leptospira serogroups Icterohaemorrhagiae and Canicola in the United States" (Walker et al., 2018) . Validity and disposition requirements submitted to the Center for Veterinary Biologics (CVB) are provided for serials (numbered lots) of commercial product potency tested for serogroups Canicola and Icterohaemorrhagiae in support of the Virus-Serum-Toxin Act (VSTA). Time course data for hamster loss after challenge with various concentrations of Leptospira during codified potency testing are also presented. The dose of Leptospira lethal to 50% of hamsters (LD50) was calculated by the Dragstedt-Behrens method for the in vivo data collected, and the equation is described here.
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Value of the data
The retrospective analysis data can be used by policy makers, managers, and all related stakeholders, companies, agencies, and institutes in conjunction with regulatory testing data in other countries to assist global harmonization decisions for veterinary vaccine release.
Data associated with regulatory leptospiral vaccine testing is accessible to basic researchers. Survival time course data for hamsters treated with various immunizations and challenge inoculums are provided. These may be used by other research groups in understanding the LD50 and disease progression variables for leptospirosis.
Data
The codified leptospiral potency assays require ten hamsters (Harlan Sprague Dawley) to be vaccinated, and approximately two weeks later, the vaccinates and ten unvaccinated controls receive the same leptospiral challenge. Additional unvaccinated controls receive serial titrations of the leptospiral challenge to calculate the LD50. For a valid test, eight of ten controls receiving the same challenge inoculum as the vaccinates must succumb to disease and serial titration of the challenge must yield an LD50 of 10-10,000. The data presented extends the reproducibility of the recently published work exploring the validity requirements of codified potency testing of leptospiral vaccines [1] . Table 1 provides raw retrospective validity and disposition data on Title 9, Code of Federal Regulations (9 CFR) 113.102 -113.103 potency testing for serial release. Fig. 1 depicts the formula for LD50 determination. Tables 2 and 3 contain the survival data for hamsters vaccinated with both potent and subpotent bacterins after receiving a range of leptospiral concentrations. It also includes the back-titrations used to determine LD50 for each test. Figs. 2 and 3 are Kaplan-Meier curves of mortality over time for the in vivo experiments in Tables 2 and 3. 2. Experimental design, materials, and methods
Retrospective data
Serial release testing between July 2011 and April 2015 of vaccines containing Leptospira serogroups Canicola and Icterohaemorrhagiae fractions were submitted to the CVB according to 9 CFR 116. Each entry represents one stage of a 9 CFR potency test, and entries were removed if (1) the incorrect number of animals were used in the challenge group, (2) the serial was destroyed causing the submitted data to potentially be incomplete, (3) animals escaped housing during testing, (4) animals were ill from other causes at the time of testing, or (5) the LD50 was not reported. No confidential business information including veterinary biologics manufacturer's identification, testing location, or testing dates was listed.
Vaccination-challenge assays and LD50 determination
Supplemental Assay Methods (SAMs) 609 and 610 describe the hamster potency tests for Leptospira interrogans serogroup Canicola and Leptospira interrogans serogroup Icterohaemorrhagiae bacterins [2, 3] . Specific immunization procedures for this data are described elsewhere [1] . SAMs 609 and 610 require LD50 estimation via Reed-Muench, Dragstedt-Behrens, or Spearman-Karber. For this work, the Dragstedt-Behrens method described here was used [4, 5] . This is not a general explanation of the Dragstedt-Behrens method, which can accommodate more general dilution sequences, including unequally spaced dilutions. Rather the following explanation is specific to the accompanying data and the work reported in this paper, which uses ten-fold serial dilutions. For this calculation:
Let A j ¼ the cumulative deaths for dilution j, from most dilute to least dilute. Let B j ¼ the cumulative survivors for dilution j, from least dilute to most dilute. Let the cumulative percent dead at dilution j be C j ¼
Â 100% Define C left as the lowest C j 4 50%, and define C right as the highest C j less than 50%. Let d left and d right be the corresponding dilutions, which are the dilutions that bracket the 50% cumulative response, whose unknown dilution we call d 50 . Since the challenge dilution and the d left are always the same during regulatory leptospiral potency testing, the exact dilutions cancel each other when calculating LD50 per animal. A series of tenfold serial dilutions from the standard challenge during titrations will always allow calculation of LD50 per animal regardless of the specific challenge dilution from the liver homogenate used.
